5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.

@article{Gallagher201256Methylenedioxy2aminoindaneFL,
  title={5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.},
  author={Cathal T. Gallagher and Sulaf Assi and Jacqueline L Stair and Suzanne Fergus and Ornella Corazza and John M Corkery and Fabrizio Schifano},
  journal={Human psychopharmacology},
  year={2012},
  volume={27 2},
  pages={106-12}
}
OBJECTIVES The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides… CONTINUE READING